The pulmonary microbiome in non-cystic fibrosis bronchiectasis.

M. Mac Aogáin (Singapore, Singapore)

Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mac Aogáin (Singapore, Singapore). The pulmonary microbiome in non-cystic fibrosis bronchiectasis.. 4066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019


Immuno-allertypes in non-cystic fibrosis  bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019


Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


NTM in cystic fibrosis and non-CF bronchiectasis
Source: ERS Course 2015
Year: 2015

Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018


Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Cystic fibrosis fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Management and prevention of non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – PG9 Lower respiratory tract infection in children
Year: 2015




Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016


The relationship between airway bacterial load and airways inflammation in stable non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Year: 2011


Non-tuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019